Központi Könyvtár

Semmelweis Egyetem

Központi Könyvtár

Semmelweis Egyetem
BIOMEDICAL AND LIFE SCIENCES COLLECTION - ÚJ ELŐADÁSAI

Tisztelt Olvasóink!

Ezúton szeretnénk figyelmükbe ajánlani a HS Talks - Biomedical & Life Sciences Collection legújabb online szemináriumait.

Az adatbázis a következő témájú szemináriumokkal bővült: Hepatitis CPI 3-kinasesdiabetesASDrabiescolonDM and CKDSARS-CoV-2Nanotechnologies.

Hepatitis C virus: discovery, cure and protection
Dr. Matthew Evans Icahn School of Medicine at Mount Sinai, USA

PI 3-kinases and lipid messengers
Prof. Bart Vanhaesebroeck University College London, UK

Antibodies to control or prevent type 1 diabetes
Dr. Robert Hilbrands Brussels Free University, Belgium

Evidence-based practices for children with autism spectrum disorder
Dr. Brian Reichow University of Florida, USA 

Understanding and assessing language and communication in children with ASD
Dr. Patricia A. Prelock The University of Vermont, USA 

Chronic spontaneous and inducible urticaria
Prof. Marcus Maurer Charité - Universitätsmedizin Berlin, Germany 

Outcomes in children born after assisted reproductive technology
Prof. Alastair Sutcliffe UCL GOS Institute of Child Health, UK 

Eliminating human rabies deaths: rabies as a disease and a global burden
Prof. Sarah Cleaveland, OBE, FRS University of Glasgow, UK 

Eliminating human rabies deaths: targeting the elimination of rabies
Prof. Sarah Cleaveland, OBE, FRS University of Glasgow, UK

Drug delivery to the colon
Dr. Susan Hua University of Newcastle, Australia 

Selection bias in studies with unequal allocation
Dr. Olga M. Kuznetsova Merck & Co., Inc, USA 

Managing hyperglycaemia in people with DM and CKD: establishing chronic co-pathology
Dr. Peter Winocour Clinical Director, ENHIDE, UK

Managing hyperglycaemia in people with DM and CKD: cardiovascular disease (CVD) involvement
Dr. Peter Winocour Clinical Director, ENHIDE, UK 

Predicting COVID-19 outbreaks by measuring SARS-CoV-2 RNA in sewage sludge
Prof. Jordan Peccia Yale University, USA 

The evolutionary origin of SARS-CoV-2
Dr. Feng Gao Duke University Medical Center, USA

Medical wearable devices for tracking symptoms of COVID-19
Prof. John Rogers Northwestern University, USA

Risk of re-emergence of COVID-19 after exit from lockdown
Dr. Leonardo Lopez Barcelona Institute for Global Health, Spain

Predicting COVID-19 outbreaks by measuring SARS-CoV-2 RNA in sewage sludge
Prof. Jordan Peccia Yale University, USA

Medical wearable devices for tracking symptoms of COVID-19
Prof. John Rogers Northwestern University, USA

The evolutionary origin of SARS-CoV-2
Dr. Feng Gao Duke University Medical Center, USA

Risk of re-emergence of COVID-19 after exit from lockdown
Dr. Leonardo Lopez Barcelona Institute for Global Health, Spain

Challenges of accelerated vaccine development
Dr. Jakub Simon Director of Clinical Research, Vaccines, Merck Research Laboratories, USA

Convalescent plasma therapy as a treatment for COVID-19
Dr. Manu Shankar-Hari NIHR Clinician Scientist & Consultant in ICM, Guy's and St Thomas' NHS Foundation Trust., UK

Immune responses to viruses
Prof. Paul Klenerman University of Oxford, UK

Remdesivir COVID-19 clinical trial
Prof. Mahesh Parmar University College London, UK

SARS-CoV and other emerging coronaviruses
Prof. Ralph Baric University of North Carolina at Chapel Hill, USA

The development of SARS-CoV-2 vaccines
Prof. Peter Hotez Baylor College of Medicine, USA

Principles of virology
Prof. Vincent Racaniello Columbia University, USA

Nanotechnologies in the fight against coronaviruses
Prof. Sabine Szunerits University of Lille, France

Introduction to the immune system
Prof. Herman Waldmann University of Oxford, UK

Hematopoiesis: the making of an immune system
Prof. Paul J. Fairchild University of Oxford, UK 

Regulated cell death mechanisms and their crosstalk with the immune system 1
Dr. Luis Alberto Baena-Lopez University of Oxford, UK

Regulated cell death mechanisms and their crosstalk with the immune system 2
Dr. Luis Alberto Baena-Lopez University of Oxford, UK

The immunology of multiple sclerosis
Dr. Joanne Jones University of Cambridge, UK

MRD driven multiple myeloma treatment: next step forward
Prof. Ola Landgren Memorial Sloan Kettering Cancer Center, USA

Fundamentals of protein chromatography: basic protein purification
Emeritus Prof. Richard R. Burgess University of Wisconsin-Madison, USA

Fundamentals of protein chromatography: protein chromatography
Emeritus Prof. Richard R. Burgess University of Wisconsin-Madison, USA

Mosaicism
Prof. Eamonn Maher University of Cambridge, UK

Darwin's legacy: evolutionary interactions
Prof. Vassiliki Betty Smocovitis University of Florida, USA

Tolerance induction to clotting factors with monoclonal antibodies
Prof. Luís Graça University of Lisbon, Portugal 

Schistosomiasis
Prof. Russel Stothard Liverpool School of Tropical Medicine, UK 

Hard tissue biology in human health and evolution: craniofacial biology
Prof. Timothy Bromage New York University, USA

Liver and spleen
Emeritus Prof. Kapil S. Satyapal University of KwaZulu-Natal, South Africa 

Approaches for elucidating genetic susceptibility to SARS-CoV-2
Dr. Kenneth Baillie University of Edinburgh, UK 

Human challenge trials for vaccines against COVID-19
Prof. Peter Smith London School of Hygiene & Tropical Medicine, UK 

The immune system response to the SARS-CoV-2 virus: July 2020 update
Prof. Paul Klenerman University of Oxford, UK

The impact of COVID-19 in the elderly and in care homes
Dr. David Strain University of Exeter Medical School, UK

Remdesivir COVID-19 clinical trial
Prof. Mahesh Parmar University College London, UK 

The development of SARS-CoV-2 vaccines
Prof. Peter Hotez Baylor College of Medicine, USA

Nanotechnologies in the fight against coronaviruses
Prof. Sabine Szunerits University of Lille, France

Convalescent plasma therapy as a treatment for COVID-19
Dr. Manu Shankar-Hari NIHR Clinician Scientist & Consultant in ICM, Guy's and St Thomas' NHS Foundation Trust., UK

INFβ therapy for COVID-19: the new SNG001 drug
Prof. Stephen Holgate University of Southampton, UK

The immunogenicity problem in antibody therapy
Prof. Herman Waldmann University of Oxford, UK

Successes and failures with vaccines
Prof. Stanley Plotkin University of Pennsylvania, USA 

The immune system response to the SARS-CoV-2 virus: an update
Prof. Paul Klenerman University of Oxford, UK 

SARS-CoV and other emerging coronaviruses
Prof. Ralph Baric University of North Carolina at Chapel Hill, USA

Novel approaches to diagnosis of viral infections
Prof. W. Ian Lipkin Columbia University, USA 

Implementation of adaptive methods in early phase clinical trials
Prof. Gina Petroni University of Virginia, USA

Inorganic nanostructured interfaces for therapeutic delivery
Prof. Tejal Desai University of California, San Francisco, USA 

Vaccine delivery
Prof. Sevda Şenel Hacettepe University, Turkey 

Intravenous immunoglobulins: clinical evidence
Prof. Shaye Kivity Sheba Medical Center, Israel

Strategies for exiting the lockdown
Prof. David McCoy Queen Mary University of London, UK

INFβ therapy for COVID-19: the new SNG001 drug
Prof. Stephen Holgate University of Southampton, UK 

SARS-CoV-2 human monoclonal antibody therapy
Prof. James Crowe Vanderbilt Vaccine Center, USA

The COVID-19 coronavirus outbreak: May 2020 update
Prof. Jonathan Temte University of Wisconsin, USA

Antiviral drugs (non-HIV)
Prof. Megan Shaw Mount Sinai, USA 

The type I interferon system and viruses
Dr. Adolfo Garcia-Sastre Icahn School of Medicine at Mount Sinai, USA

The immunogenicity problem in antibody therapy
Prof. Herman Waldmann University of Oxford, UK 

Antibody engineering: beginnings to bispecifics and beyond
Dr. Ian Wilkinson Absolute Antibody, UK

Phage display for generating monoclonal antibodies
Dr. Andre Frenzel YUMAB GMBH, Germany 

Usage of vaccines and therapeutics in public health emergencies 1
Prof. Gary Kobinger Laval University, Canada

The COVID-19 coronavirus outbreak: a follow-up interview - (open access)
Prof. Jonathan Temte University of Wisconsin, USA 

SARS-CoV and other emerging coronaviruses
Prof. Ralph Baric University of North Carolina at Chapel Hill, USA

COVID-19 epidemiology and potential treatments: follow up interview - (open access)
Prof. Ralph Baric University of North Carolina at Chapel Hill, USA


Principles of virology

Prof. Vincent Racaniello Columbia University, USA

Immune responses to viruses
Prof. Paul Klenerman University of Oxford, UK

Fundamentals of HIV biology 
Prof. Viviana Simon Icahn School of Medicine at Mount Sinai, USA

Cytomegalovirus biology 
Prof. Domenico Tortorella Icahn School of Medicine at Mount Sinai, USA

Binding kinetics in drug discovery 
Dr. Rumin Zhang VP of Discovery, Rafael Pharmaceuticals, USA

Subarachnoid hemorrhage (SAH) 
Prof. R. Loch Macdonald University of San Francisco, USA

Treating diabetes in the elderly: overcoming challenges 
Dr. David Strain University of Exeter Medical School, UK

Ethnic variation in the susceptibility to diabetes 
Prof. Jonathan Shaw Baker IDI Heart and Diabetes Institute, Australia

Disorders of gastric function: gastroparesis and functional dyspepsia 1 
Dr. Braden Kuo Harvard Medical School, USA

Disorders of gastric function: gastroparesis and functional dyspepsia 2 
Dr. Braden Kuo Harvard Medical School, USA

Pediatric stroke: cerebrovascular injury in the developing brain 
Prof. Adam Kirton University of Calgary, Canada

Prevention: carotid endarterectomy, angioplasty, and stenting 
Prof. Brian Hoh University of Florida, USA

Measles 
Prof. Diane E. Griffin Johns Hopkins Bloomberg School of Public Health, USA

Chagas disease 
Prof. Peter Hotez Baylor College of Medicine, USA

The immune system response to the SARS-COV-2 virus: an update 
Prof. Paul Klenerman University of Oxford, UK

Development of an intranasal vaccine for SARS-CoV-2 
Dr. Scot Roberts CSO, Altimmune, USA

Development of PRO-140 (Leronlimab) as a treatment for COVID-19 
Dr. Jacob Lalezari Quest Clinical Research, USA

COVID-19 epidemiology and potential treatments: follow up interview 
Prof. Ralph Baric University of North Carolina at Chapel Hill, USA


COVID-19 epidemiology and potential treatments: follow up interview - (open access)
Prof. Ralph Baric University of North Carolina at Chapel Hill, USA 

Development of PRO-140 (Leronlimab) as a treatment for COVID-19 - (open access)
Dr. Jacob Lalezari Quest Clinical Research, USA 

The impact of genomic architecture and diversity on infectious diseases
Prof. Vincent Chow National University of Singapore, Singapore

Antiviral drugs (non-HIV)
Prof. Megan Shaw Mount Sinai, USA 

Novel approaches to diagnosis of viral infections
Prof. W. Ian Lipkin Columbia University, USA

The type I interferon system and viruses
Dr. Adolfo Garcia-Sastre Icahn School of Medicine at Mount Sinai, USA

HIV cure: harnessing innate and adaptive strategies
Prof. Luis Montaner The Wistar Institute, USA

SARS-CoV and other emerging coronaviruses
Prof. Ralph Baric University of North Carolina at Chapel Hill, USA

The COVID-19 outbreak: an update on the SARS-CoV-2 virus - (open access)
Prof. Ralph Baric University of North Carolina at Chapel Hill, USA

The COVID-19 coronavirus outbreak: a follow-up interview - (open access)
Prof. Jonathan Temte University of Wisconsin, USA 

SARS-CoV-2 vaccine development - (open access)
Prof. Stanley Plotkin University of Pennsylvania, USA

SARS-COV-2: What we need to know and possible future therapies - (open access)
Prof. Stanley Perlman University of Iowa, USA

SARS-COV-2: What we need to know and possible future therapies - (open access)
Prof. Stanley Perlman University of Iowa, USA 

SARS-COV-2 vaccine development: where are we now? - (open access)
Prof. Gary Kobinger Laval University, Canada 

The current understanding of the biology of the SARS-COV-2 virus - (open access)
Prof. Peter Palese Mount Sinai School of Medicine, USA 

SARS-COV-2 vaccine: current biological targets and considerations - (open access)
Dr. Adolfo Garcia-Sastre Icahn School of Medicine at Mount Sinai, USA 

The paediatric response to the SARS-COV-2 virus and what we can learn from it - (open access)
Prof. Sallie Permar Duke University Medical School, USA 

The COVID-19 coronavirus outbreak: a follow-up interview - (open access)
Prof. Jonathan Temte University of Wisconsin, USA 

SARS-CoV-2 vaccine development - (open access)
Prof. Stanley Plotkin University of Pennsylvania, USA 

The immune system response to the SARS-COV-2 virus - (open access)
Prof. Paul Klenerman University of Oxford, UK 

SARS-CoV and other emerging coronaviruses
Prof. Ralph Baric University of North Carolina at Chapel Hill, USA 

Emerging or newly discovered viral causes of acute lower respiratory tract infections worldwide
Dr. Marietjie Venter NICD, South Africa 

Usage of vaccines and therapeutics in public health emergencies 1
Prof. Gary Kobinger Laval University, Canada 

Novel approaches to diagnosis of viral infections
Prof. W. Ian Lipkin Columbia University, USA

Mitochondrial diseases: an update
Dr. Ayesha Saleem University of Manitoba, Canada

The mast cells: the mastermind cells of the allergic inflammatory reaction
Prof. Adrian Piliponsky University of Washington, USA 

Eosinophil functions in allergic diseases: an evolving paradigm
Prof. Lisa A. Spencer University of Colorado School of Medicine, USA

The role of basophils in allergy
Prof. Franco H. Falcone Justus Liebig University Giessen, Germany

An introduction to autism and the autism spectrum
Prof. Fred Volkmar Yale University School of Medicine, USA 

The epidemiology of autism spectrum disorders: history and current estimates
Prof. Eric Fombonne Oregon Health and Science University, USA

The epidemiology of autism spectrum disorders: time trends and world perspectives
Prof. Eric Fombonne Oregon Health and Science University, USA 

Assessment and diagnosis of individuals with Autism Spectrum Disorder (ASD)
Dr. Julie M. Wolf Yale Child Study Center, USA

Plant-soil feedbacks
Dr. Ciska Veen Netherlands Institute of Ecology, Netherlands

Cholesterol oxidation between health and disease
Prof. Giuseppe Poli University of Torino, Italy

Tropical snakebite
Prof. Robert Harrison Liverpool School of Tropical Medicine, UK

Innovative and effective subject randomization methods
Prof. Wenle Zhao Medical University of South Carolina, USA

The COVID-19 outbreak: an update on the SARS-CoV-2 virus
Prof. Ralph Baric University of North Carolina at Chapel Hill, USA

The immune system response to the SARS-COV-2 virus
Prof. Paul Klenerman University of Oxford, UK

The current understanding of the biology of the SARS-COV-2 virus
Prof. Peter Palese Mount Sinai School of Medicine, USA

The paediatric response to the SARS-COV-2 virus and what we can learn from it
Prof. Sallie Permar Duke University Medical School, USA

The COVID-19 coronavirus outbreak: a follow-up interview
Prof. Jonathan Temte University of Wisconsin, USA

The COVID-19 coronavirus outbreak: a current view
Prof. Jonathan Temte University of Wisconsin, USA

 
The immune system response to the SARS-COV-2 virus 
Prof. Paul Klenerman University of Oxford, UK

The immune system: an overview - innate immunity 
Prof. Shiv Pillai Harvard Medical School, USA

The immune system: an overview - adaptive immunity 
Prof. Shiv Pillai  Harvard Medical School, USA

The complement system - an introduction for undergraduates 
Prof. Michael Holers  University of Colorado School of Medicine, USA

Vaccine delivery 
Prof. Sevda Şenel  Hacettepe University, Turkey

Biodefense challenges 
Dr. David Franz  US Army (Retired) and Kansas State University., USA

History of vaccines 
Prof. Stanley Plotkin  University of Pennsylvania, USA


Successes and failures with vaccines 
Prof. Stanley Plotkin University of Pennsylvania, USA

The COVID-19 outbreak: an update on the SARS-CoV-2 virus - (open access) 
Prof. Ralph Baric University of North Carolina at Chapel Hill, USA 

Vaccine delivery 
Prof. Sevda Şenel Hacettepe University, Turkey

The COVID-19 coronavirus outbreak: a current view - (open access) 
Prof. Jonathan Temte University of Wisconsin, USA 

SARS-CoV and other emerging coronaviruses 
Prof. Ralph Baric University of North Carolina at Chapel Hill, USA 

Vaccine adjuvants 1 
Dr. Derek O'Hagan GSK Vaccine Research, USA